Pediatric Seizures Flashcards

1
Q

A seizure is:
a) Excessive asynchronous neuronal activity
b) Reduced asynchronous neuronal activity
c) Excessive synchronous neuronal activity
d) Reduced synchronous neuronal activity

A

c.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Adjusting antiseizure medications (ASMs) is:
a) Complex
b) A unique opportunity to flex pharmacist knowledge
c) Best left to neurologists
d) A & B
e) A & C

A

d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Status epilepticus is a _______ _________

A

medical emergency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is status epilepticus? (2)

A
  1. Any recurrent or continuous seizure activity lasting > 30 minutes in which the patient does not regain baseline mental status
    - Or a cluster of seizures that does not return to baseline for > 30 mins
  2. Any seizure that does not stop within 5 minutes should be treated as impending SE
    - Operationally seizures lasting >5 mins or repetitive seizures for > 5 min are treated as SE to prevent consequences and increase response to tx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain what t1 and t2 of seizure frequency means

A

t1 = When a seizure is likely to be prolonged leading to continuous seizure activity
t2 = When a seizure may cause long term consequences (including neuronal injury, neuronal death, alteration of neuronal networks and functional deficits)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What class of drugs and what dosing frequency is often given to pts for acute seizure treatment to reduce risk of progression to status epilepticus?

A

On demand BZDs to use prn at the onset of seizures to decrease risk of progression to SE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the treatment options for pediatrics (> 3 months) to treat acute seizure/reduce risk of progression to status epilepticus? (2)

A
  1. Midazolam intranasal 0.2 to 0.3 mg/kg/dose or buccal 0.2 to 0.5 mg/kg/dose (max 10mg)
    - Injectable midazolam (5 mg/mL concentration preferred)
    - Via nasal atomizer for nasal administration; split dose into each nostril
  2. Not as common but lorazepam buccal 0.1mg/kg (max 4mg) could be used too.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the treatment options for infants (< 3 months) to treat acute seizure/reduce risk of progression to status epilepticus?

A

Rectal diazepam 0.5mg/kg/dose (max 20mg) - tend not to use because pretty traumatic for both the patient and the caregivers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain how to administer intranasal midazolam

A
  • Nasal atomizer - creates fine mist as you push the solution through it. (That’s the cone looking thing).
  • Key things are midazolam need syringes, mucosal atomizer needed to administer. Atomizer can be re-used. Tilt the pt’s head back. Go in, give a quick push and gently atomize it. Split the dose between both nostrils to maximize surface area for absorption.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The etiology of seizures is unknown, but what are some potential factors/causes? (6)

A
  1. Structural
  2. Genetic
  3. Infectious
  4. Metabolic
  5. Immune
  6. Unknown
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define a focal seizure

A

Starting/affecting one hemisphere of the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define a generalized seizure

A

Starting/affecting both hemispheres at the same time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define epilepsy syndromes

A

Refers to clusters of features that may occur together, including seizure type, EEG findings, imaging findings, age-dependent features (e.g., age at onset or remission), specific comorbidities (e.g., psychiatric illness), triggers and sometimes prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 2 main epilepsy syndromes we talked about?

A
  1. Lennox-Gastaut Syndrome (LGS)
  2. Dravet syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the clinical features of LGS? (2)

A
  1. Tonic, atonic, myoclonic seizures
  2. Atypical absences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the clinical features of Dravet syndrome? (3)

A
  1. Prolonged, often febrile, clonic seizures.
  2. Repeated febrile and afebrile seizures.
  3. Myoclonus common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

1st line for absence seizures is?

A

Ethosuximide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ethosuximide for other seizure types?

A

No, only absence seizures. Do not use as monotherapy if mixed seizure types, even if one of these is absence seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the advantages of ethosuximide? (4)

A
  1. Lower rates of attention difficulties compared to VPA
  2. Works quickly
  3. Generally well-tolerated
  4. Few drug interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the disadvantage of ethosuximide? (1)

A

Narrow-spectrum of activity
- Only a good choice to use for uncomplicated absence seizures
- Does not confer protection for generalized tonic-clonic seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the adverse effects of ethosuximide? (3)

A
  1. CNS effects
    - Drowsiness, dizziness, behavioural changes
  2. GI effects
    - Dose-related 🡪 Can divide dose to minimize
  3. Rare: blood dyscrasias, skin rashes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What should be monitored when on ethosuximide? (2)

A

CBC and platelets (annually)

23
Q

What is infantile epileptic spasms syndrome? (3)

A
  1. Epileptic spasms most often occur in “clusters” on awakening and involve tonic limb (+/- head) flexion or extension:
    - Each spasm lasts less than 3 seconds
    - Repeats every 5 to 10 seconds
    - For a period of 5 to 15 mins
  2. May have a distinctive, disordered EEG pattern called hypsarrhythmia
  3. May have psychomotor arrest
24
Q

How should infantile epileptic spasms syndrome be treated?

A

Treat early and aggressively to prevent long-term sequelae (e.g., intellectual delays, refractory seizures)

25
Q

Treatment options for infantile epileptic spasms syndrome include: (2)

A
  1. Hormonal therapy (oral prednisolone or IM/subcut ACTH)
  2. Vigabatrin
    Other ASMs are ineffective
26
Q

True or False? Vigabatrin acts on GABA receptors

A

False - structural analog of GABA, but does NOT act on GABA receptors

27
Q

What is the MOA of vigabatrin?

A

Irreversible inhibition of GABA-transaminase leads to ↑ [GABA] in the CNS = ↑ neuro-inhibition

28
Q

Vigabatrin metabolized how?

A

Insignificantly - mainy excreted unchanged in the urine –> renally adjust

29
Q

What are the ADRs of vigabatrin? (3)

A
  1. Visual abnormalities, including permanent vision loss
  2. Vomiting and upper resp tract infections
  3. Asymptomatic MRI changes
30
Q

Lennox-Gastaut Syndrome (LGS) is developmental and epileptic encephalopathy with: (3)

A
  1. Multiple drug-resistant seizure types, including but not limited to:
    - Tonic
    - Atonic (“drop attacks”)
    - Atypical absence
    - Generalized tonic-clonic
  2. Typical EEG pattern
    - Generalized slow spike-and-wave
    - Generalized paroxysmal fast activity
  3. Intellectual disability
31
Q

What is first-line treatment for LGS?

A

Valproate
(Maybe rufinamide if in Ontario)

32
Q

What is 2nd-line treatment for LGS?

A

Lamotrigine (monotherapy or adjunct)

33
Q

What is 3rd-line adjunctive treatment for LGS (NICE guidelines)? (4)

A
  1. Topiramate
  2. Rufinamide
  3. Cannabidiol
  4. Clobazam
34
Q

What is 4th-line adjunctive treatment for LGS (NICE guidelines)? (2)

A
  1. Ketogenic diet
  2. Felbamate
35
Q

What is the approved indication for rufinamide?

A

Adjunctive treatment of seizures associated with LGS in patients 4+

36
Q

What is the MOA of rufinamide?

A
  1. Exact MOA unknown.
  2. Prolongs the inactive state of Na+ channels, limiting repetitive firing of Na+ dependent action potentials.
37
Q

What drug interactions to be aware of with rufinamide? (2)

A
  1. Weak CYP3A4 inhibitor
  2. Valproate may ↑ rufinamide levels
38
Q

What are the ADEs of rufinamide? (5)

A
  1. Headache
  2. Shortened QT interval
  3. Tremor
  4. Vomiting, nausea
  5. Leukopenia
39
Q

What is Dravet Syndrome? (3)

A

Drug-resistant developmental and epileptic encephalopathy [DEE] with:
- Seizures of various types, often starting with early-onset febrile seizures in infancy
- Progressive cerebral and cerebellar atrophy
- Developmental delays and intellectual disability

40
Q

Dravet syndrome is 80% due to what?

A

Due to loss of function mutation in SCN1A (a Na+ channel gene)

41
Q

What are the sodium channel blocking ASMs? (9)

A
  1. Carbamazepine
  2. Oxcarbazepine
  3. Eslicarbazepine
  4. Lacosamide
  5. Lamotrigine
  6. Rufinamide
  7. Phenytoin
  8. Topiramate
  9. VPA
42
Q

How is Dravet Syndrome treated?

A

Valproic acid (VPA) in children?
- Contraindicated in children less than 2 years old due to fatal hepatotoxicity
- If absolutely necessary, can use levocarnitine to mitigate risk (usually at 50 mg/kg/day)

43
Q

What is the MOA of fenfluramine?

A

Not fully understood but may promote serotonin release, act as a serotonin agonist, and inhibit serotonin transporters and reuptake

44
Q

How efficacious is fenfluramine?

A

Efficacy has been shown to be maintained out to 3 years and decreases risk of SUDEP and all cause mortality in Dravet Syndrome

45
Q

Fenfluramine has a significant interaction with ___________

A

stiripentol

46
Q

Fenfluramine is only available through…?

A

the Health Canada Special Access Program

47
Q

What are the approved indications for stiripentol?

A

Combined treatment with clobazam + valproate for refractory GTC seizures in patients with Dravet Syndrome not controlled with clobazam and valproate alone

48
Q

True or False? Stiripentol capsules and powder is interchangeable

A

True - BUT not totally bioequivalent, so slight differences in efficacy

49
Q

What is the MOA of stiripentol?

A
  1. Precise MOA unknown.
  2. May ↑ GABAergic inhibitory neurotransmission
50
Q

What are the DIs of stiripentol? (2)

A
  1. Moderately inhibits CYP1A2, CYP2C19
  2. Major substrate for CYP1A2, CYP2C19, CYP3A4
51
Q

What are the ADEs of stiripentol? (5)

A

Serious:
1. Delirium
2. Hallucinations
Other:
3. Drowsiness
4. Decreased appetite
5. Thrombocytopenia

52
Q

What is the cannabidiol that is FDA approved for LGS or Dravet syndrome?

A

Epidiolex (2+ years old)

53
Q

What are the 3 big non-pharm treatments for pediatric seizures?

A
  1. Keto diet - consider if have not responded to appropriate ASM therapy (treatment of choice in GLUT1DS)
  2. Surgery
  3. Vagus Nerve Stimulation (VNS)
54
Q

What to know/consider about stopping ASM treatment in peds? (3)

A
  1. Children with epilepsy often go into remission (become “seizure free”)
    - Although risk of relapse still depends on many factors
  2. Evidence supports stopping therapy after at least 2 years of seizure freedom
  3. The approach taken considers adverse effects with chronic treatment and risk of seizures when deciding to stop or continue